Neptika (Tianeptine Sodium)

Tianeptine Sodium, the active ingredient in Neptika, is an antidepressant presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients and works by influencing central neurotransmitter systems to improve mood and functional outcomes.

GNH USA supplies Neptika as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and timely delivery across multiple regions.

Neptika (tianeptine sodium) is used in the management of depressive disorders.

- Major depressive disorder: reduces core depressive symptoms and improves overall mood. - Depressive relapse prevention: helps maintain remission after initial response. - Adjunctive therapy for anxiety symptoms: may alleviate comorbid anxiety in depressed patients.

Common side effects are generally mild and may resolve with continued therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient tension‑type headaches. - Dizziness: occasional light‑headedness. - Dry mouth: reduced salivation. - Insomnia: difficulty initiating sleep. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Seizures: rare convulsive episodes. - Severe liver injury: signs of hepatic dysfunction. - Suicidal ideation: emergence or worsening of suicidal thoughts. - Cardiac arrhythmia: irregular heart rhythms. - Hypersensitivity reactions: rash, swelling, or anaphylaxis. - Serotonin syndrome: rare but potentially life‑threatening condition when combined with other serotonergic agents.

Before initiating therapy, clinicians should consider several safety aspects.

- Psychiatric assessment: evaluate baseline mood and suicidal risk. - Hepatic function: monitor liver enzymes in patients with liver disease. - Discontinuation: avoid abrupt cessation to reduce withdrawal symptoms. - Drug dependence: assess for potential misuse, especially in long‑term use. - Concomitant CNS depressants: use caution when combined with alcohol or sedatives. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Tianeptine sodium may interact with several medication classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonergic effects. - Other serotonergic agents (e.g., SSRIs, SNRIs): potential serotonin syndrome. - Central nervous system depressants (e.g., benzodiazepines, alcohol): enhanced sedation.

Moderate Interactions (Monitor Closely): - CYP450 inhibitors (e.g., fluoxetine, fluvoxamine): may increase plasma levels. - Antihypertensives: possible additive blood‑pressure lowering. - Warfarin: monitor INR for altered anticoagulation.